Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions
A legfontosabb adatok
- Ki végzi
- University of Leipzig
- Hol
- Németország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 120 fő, tervezett
- Kezdés
- 2024. febr. 13.
- Várható befejezés
- 2032. dec. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Intravascular lithotripsy
- Standard lesion preparation
- A regiszteradat frissítve
- 2026. május 6.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with blocked or narrowed leg arteries (femoropopliteal) that have severe calcium build-up. It compares two ways to prepare the artery before a Supera stent is placed.
- Életkor
- 18 years and older
- Nem
- All sexes
- A betegség stádiuma
- Peripheral arterial disease with symptoms, Rutherford Classification 2-5. The artery is narrowed by ≥ 70%, the lesion is ≥ 10cm (3,9 in) long, and it has severe calcium (PACSS Grade 4) on both sides, extending ≥50mm. Vessel diameter is ≥ 4 mm and ≤ 6.5 mm.
- Korábbi kezelés
- No previous stent in the treated lesion. A stent elsewhere in the same vessel must be at least 3cm (1,2 in) away. No prior vascular surgery of the treated lesion.
A részvétel fő kizáró okai
- Stroke or heart attack within 3 months before joining
- Fresh blood clot or aneurysm in the treated artery
- Major amputation above the ankle in the same leg
- Pregnant or breast-feeding
- Receiving immunosuppressant therapy, or life expectancy of less than one year
A regiszter feltételei, szó szerint
Mind a 26 feltétel megnézéseKevesebb
Ki vehet részt
- Subject age ≥ 18
- Subject has been informed of the nature of the study, agrees to participate, and has signed a Medical Ethics Committee approved inform consent form
- Subject understands the duration of the study, agrees to attend follow-up visits, and agrees to complete the required testing
- Rutherford Classification 2-5
- Subject has a de novo or restenotic lesion in SFA and/or PPA not exceeding the medial femoral epicondyle with ≥ 70% stenosis documented angiographically
- No previous stent in the target lesion, if target vessel was previously stented the stent should be at least 3cm apart
- Target lesion length is ≥ 10cm, no maximum lesion length limit
- Severe calcification on fluoroscopy defined by PACSS Grade 4: 1) bilateral calcification and 2) extending ≥50mm in length
- Multiple lesions with max. 3cm healthy vessel segment in between lesions can be considered at the discretion of the operator as one lesion
- Reference vessel diameter (RVD) ≥ 4 mm and ≤ 6.5 mm by visual estimation
- Patency of at least one infrapopliteal artery to the ankle (< 50% diameter stenosis) in continuity with the native femoropopliteal artery
- A guidewire has successfully traversed the target treatment segment (both intraluminal and subintimal crossing allowed)
Ki nem vehet részt
- Presence of a stent in the target lesion, at least 3cm from any previously stent in target vessel
- Prior vascular surgery of the target lesion
- Stroke or heart attack within 3 months prior to enrollment
- Enrolled in another investigational drug, device or biologic study that has not reached the primary endpoint
- Known allergies or sensitivity to heparin, aspirin, other anticoagulant/ antiplatelet therapies or contrast media that cannot be adequately pre-treated prior to index procedure
- Receiving immunosuppressant therapy
- Failure to successfully cross the target lesion
- History of major amputation (defined as amputation above ankle joint) in the same limb as the target lesion
- Significant gastrointestinal bleeding or any coagulopathy that would contraindicate the use of anti-platelet therapy
- Presence of fresh thrombus in the lesion
- Presence of aneurysm in the target vessel/s
- Life expectancy of less than one year
- Rutherford Classification of 0, 1, or 6
- Pregnant or breast-feeding females
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study is an investigator-initiated, prospective, single-center, 1:1 randomized pilot study.
A teljes eredeti leírásKevesebb
The trial evaluates the safety and efficacy of intravascular lithotripsy in comparison to standard lesion preparation using standard and/or high-pressure balloon angioplasty in patients with femoropopliteal artery disease. All patients will receive subsequent Supera stent implantation at the operator's discretion. Additional standard nitinol bare metal stent (BMS), drug-eluting stent or covered stent implantation is at the operator's discretion.
Patients will be stratified for total occlusions.
A vizsgálat 2 csoportja
- Intravascular lithotripsy armEgyéb csoport
Treatment with Lithotripsy system followed by Supera stent implantation in lesion segments with severe calcification.
Kezelés: Intravascular lithotripsy
- Standard lesion preparation armEgyéb csoport
Treatment with Balloon angioplasty with a conventional and/or high-pressure balloon angioplasty followed by Supera stent implantation in lesion segments with severe calcification.
Kezelés: Standard lesion preparation
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Performance of the Shockwave Medical Peripheral Lithotripsy System vs Standard Balloon Angioplasty for Lesion Preparation Prior to Supera Stent Implantation in the Treatment of Symptomatic Severely Calcified Femoropopliteal Lesions in PAD
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. május 6.